GYRUS CAPITAL
GYRUS CAPITAL is a Series C+ and buyout fund in the US and western-europe writing up to $1B checks into Climate and Healthcare.
- Stages
- Series C+, buyout
- Sectors
- Climate, Healthcare
- Check size
- up to $1B
- Invests in
- US-wide, western-europe
- Actively investing
- Yes
- Founded
- 2018
- Assets under management
- €1.4B
- Website
- gyruscapital.com
Thesis
Gyrus Capital is a private equity firm founded in 2018 and headquartered in Geneva, Switzerland. The firm focuses on transformational investments in small and medium-sized businesses within the healthcare and sustainability sectors. Gyrus Capital engages in both majority and significant minority buyouts, as well as growth capital investments. Their geographic scope primarily includes Western Europe and North America. Gyrus Capital's investment strategy centers on acquiring businesses with untapped potential at attractive entry prices, often involving complex transactions such as corporate carve-outs and founder successions. They emphasize value investing and aim to create value through strategic M&A and repositioning businesses toward higher-value segments. The firm targets companies with enterprise values of up to €1 billion. As of December 2023, Gyrus Capital Fund II had raised €310 million, surpassing the €215 million raised for Gyrus Fund I in 2021. With the close of Fund II, total funds raised since inception (November 2018) exceed €750 million. PitchBook data indicates Gyrus Capital Fund II has a size of $326 million, and Gyrus Capital Fund has a size of $319 million. The firm has raised €1.4 billion to date.
Common questions
Does GYRUS CAPITAL invest at the Series C+ stage?
Yes. GYRUS CAPITAL lists Series C+ and buyout among the stages it invests in.
What check size does GYRUS CAPITAL write?
GYRUS CAPITAL writes up to $1B checks.
Where does GYRUS CAPITAL invest?
GYRUS CAPITAL invests in the US and western-europe.